Drug Shortage Report for VISTITAN
| Report ID | 163618 |
| Drug Identification Number | 02429063 |
| Brand name | VISTITAN |
| Common or Proper name | VISTITAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | BIMATOPROST |
| Strength(s) | 0.03% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML LDP |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-29 |
| Estimated end date | 2022-07-08 |
| Actual end date | 2022-07-06 |
| Shortage status | Resolved |
| Updated date | 2022-07-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-07-07 | English | Compare |
| v5 | 2022-07-06 | French | Compare |
| v4 | 2022-07-06 | English | Compare |
| v3 | 2022-06-30 | English | Compare |
| v2 | 2022-06-29 | French | Compare |
| v1 | 2022-06-29 | English | Compare |
Showing 1 to 6 of 6